TH148792A - Mixed HPV particles - Google Patents

Mixed HPV particles

Info

Publication number
TH148792A
TH148792A TH1401002977A TH1401002977A TH148792A TH 148792 A TH148792 A TH 148792A TH 1401002977 A TH1401002977 A TH 1401002977A TH 1401002977 A TH1401002977 A TH 1401002977A TH 148792 A TH148792 A TH 148792A
Authority
TH
Thailand
Prior art keywords
hpv
hpv particles
mixed hpv
mixed
relates
Prior art date
Application number
TH1401002977A
Other languages
Thai (th)
Other versions
TH1401002977A (en
TH148792B (en
Inventor
รีบิคกิ
ปีเตอร์ เอ็ดเวิร์ด
Original Assignee
ยูนิเวอร์ซิตี้ ออฟ เคป ทาวน์
Filing date
Publication date
Publication of TH1401002977A publication Critical patent/TH1401002977A/en
Application filed by ยูนิเวอร์ซิตี้ ออฟ เคป ทาวน์ filed Critical ยูนิเวอร์ซิตี้ ออฟ เคป ทาวน์
Publication of TH148792A publication Critical patent/TH148792A/en
Publication of TH148792B publication Critical patent/TH148792B/en

Links

Abstract

DC60 (29/05/57) การประดิษฐ์นี้เกี่ยวกับเชื้อแพปพิลโลมาไวรัสผสมในมนุษย์ (HPV) อนุภาคที่คล้ายเชื้อไวรัส (VLP) มีเส้นผ่านศูนย์กลางประมาณ 30 นาโนเมตร นอกจากนี้, การประดิษฐ์เกี่ยวกับวิธีการรักษาและ/หรือการ ป้องกันโรคติดเชื้อ HPV และ/หรือมะเร็งปากมดลูกโดยการใช้ HPV VLP ผสมของการประดิษฐ์นี้DC60 (29/05/14) This invention relates to a human papillomavirus (HPV) virus-like particle (VLP) having a diameter of approximately 30 nanometers. In addition, the invention relates to a method for treating and/or preventing HPV infection and/or cervical cancer by using the HPV VLP mixture of the present invention.

TH1401002977A 2012-12-03 Mixed HPV particles TH148792B (en)

Publications (3)

Publication Number Publication Date
TH1401002977A TH1401002977A (en)
TH148792A true TH148792A (en) 2016-04-18
TH148792B TH148792B (en) 2016-04-18

Family

ID=

Similar Documents

Publication Publication Date Title
WO2012106356A3 (en) Virus-like particles and methods of use
HK1198703A1 (en) Hpv chimaeric particle
AU2018260809A1 (en) Compounds and uses thereof for the modulation of hemoglobin
MX373884B (en) Pcv2 orf2 protein variant and virus like particles composed thereof
AU2018260808A1 (en) Compounds and uses thereof for the modulation of hemoglobin
MX2022001105A (en) Anti-tigit antibodies.
EP3046583A4 (en) Virus-like particle conjugates for diagnosis and treatment of tumors
MX354750B (en) PSEUDO-VIRAL PARTICLES (PPVs) THAT INCLUDE GLICOPROTEINS OF RABIA VIRUSES.
MY166557A (en) Quinazoline derivatives for the treatment of viral infections and further diseases
WO2015085318A3 (en) Targeted adaptive vaccines
WO2014031610A8 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
IN2014DN09173A (en)
WO2013126746A3 (en) Dll3 modulators and methods of use
MY169159A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HK1204970A1 (en) Polymer-agent conjugates, particles, compositions, and related methods of use
WO2013114367A8 (en) C10rf32 antibodies, and uses thereof for treatment of cancer
HK1217092A1 (en) Therapeutic compounds and uses thereof
MA40458A (en) Methods of treating cervical cancer
MX2015010829A (en) Therapeutic compounds and uses thereof.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
WO2015054678A3 (en) Human papilloma virus therapeutic vaccine
WO2016011049A3 (en) Compositions and methods for disease treatment using nanoparticle delivered compounds
EP4233896A3 (en) Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
IN2015DN02335A (en)
WO2014100857A8 (en) Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy